

The March CE meeting will be held on Tuesday, March 3rd. The meeting will feature Camille Heersche, DVM, Sr. Professional Services Veterinarian, Texoma Region (TX, OK). Thank you for Merck Animal Health for sponsoring the March meeting.
Bio of Dr. Heersche:
Dr. Camille Heersche is a veterinarian who earned her DVM from Kansas State University and began her career as a general practitioner in the Houston, Texas area. Here she pursued advanced training in dentistry, ultrasonography, and surgery. Within a few years, she promoted into medical management role for 16 clinics in the Dallas-Fort Worth area. In this role, she developed a passion for supporting veterinarians and developing teams. This led into an operations management role, with a focus on business health, manager development and clinic support.
Throughout her career, Dr. Heersche has maintained a passion for developing people invested in the veterinary profession. This includes volunteer work through multiple veterinary leadership development programs to support the next generation of veterinary teams.
Dr. Heersche was drawn to Merck Animal Health because of its commitment to quality products, culture of continual process improvement and innovative solutions that support the wellbeing of pets and clinics that care for them. In her role as a Sr. Professional Services Veterinarian, she is dedicated to supporting both internal and external audiences in expanding their knowledge about Merck’s products and working towards improving the lives of pets.
Outside of her work, Dr. Heersche enjoys various activities including horseback riding, bodybuilding, fishing, and training dogs.
TOPIC UPDATE:
Title: Numelvi: The Next Generation of Itch Relief
Allergic dermatitis is a commonly diagnosed condition and can be complex to manage. A new product has recently come to market support case management. Join us in learning about Numelvi, a second generation janus kinase inhibitor that provides a safe, effective, and simple itch relief to patients with allergic dermatitis.
Nobivac NXT FeLV: The next generation of non-adjuvanted protection
Description: Feline leukemia virus (FeLV) is not a new thing. We have all been talking about, reviewing, diagnosing, and managing FeLV for as long as we have been veterinarians, and the attention we pay to this retrovirus is well-deserved. Infection with FeLV sets the stage for a battle between the cat’s immune system and the virus: with lifelong consequences if the virus manages to integrate into the cat’s DNA. Safe and effective protection against this pathogen is of paramount importance, and Merck Animal Health’s Nobivac® NXT FeLV brings that protection to the next level with cutting-edge vaccine technology in a non-adjuvanted, 0.5 mL dose with a two year duration of immunity. In this presentation, learn how RNA particle vaccines are allowing us to protect our feline friends against an old virus in an entirely new way.
Cost:
$50 for non-members- DVM
$15 for staff
No additional fee for CCVMA annual members
No additional fee for Platinum members
In-Person: Please RSVP/Register at the link at bottom of the email by Sunday, March 1st.
Virtual/Zoom Meeting:
Register in advance for this meeting:
https://us02web.zoom.us/meeting/register/tZ0sdeugqjsrGdO7u4Rrvdiv5y3Amd_s5B1U
After registering, you will receive a confirmation email containing information about joining the meeting. CE certificates will be emailed 1-2 days after the meeting to the email address listed on the zoom attendance report after attendance has been verified.
Location:
Collin College McKinney Campus Conference Center
2400 Community Ave, McKinney, TX 75071
https://www.collin.edu/campuses/centralpark/maps/Cary%20A.%20Israel%20Center.p
The March meeting will be catered by Collin College. Vegetarian meals will be available.
7:00pm Meeting presentation
3.0 Hours of C.E.